Adaptimmune Therapeutics plc (NASDAQ:ADAP) Short Interest Update
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) saw a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 5,830,000 shares, a growth of 31.0% from the April 30th total of 4,450,000 shares. Currently, 2.6% of the company’s shares are sold short. Based on an […]
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) saw a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 5,830,000 shares, a growth of 31.0% from the April 30th total of 4,450,000 shares. Currently, 2.6% of the company’s shares are sold short. Based on an […]
